You are here
- Home
- Therapy Areas
Cardiovascular
The following trials provide information to treat various types of cardiovascular diseases, both for ongoing and completed clinical trials. For more information on this therapy area please click here.
- Expand All
- Collapse All
-
expand
A Randomised, Placebo-controlled, Double-blind, Parallel-group, Multicentre, Phase IIa Study to Explore the Relationship between QTcF Interval at First Dose (Loading Dose) and at Steady State after Treatment with AZD1305 Extended-release Tablets or Placebo when given to Patients with Documented AF.
- Study Id
- D3190C00019
- Disease
- atrial fibrillation
- Drug Name
- AZD1305
- Study Name
- D3190C00019
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Sep 15, 2009
- D3190C00019.pdf (511 KB)
-
expand
A Single-center, Single-blind, Randomized, Placebo-controlled, Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics After Single and Multiple Ascending Oral Doses of AZD1305 Extended-release Capsules in Healthy Male Japanese and Caucasian Subjects
- Study Id
- D3190C00015
- Disease
- atrial fibrillation
- Drug Name
- AZD1305
- Study Name
- D3190C00015
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
May 14, 2010
- D3190C00015.pdf (152 KB)
-
expand
A single-centre, single-blind, randomised, placebo-controlled phase IIa study to investigate the effect of AZD1305 given as an intravenous infusion on left ventricular performance in patients with left ventricular dysfunction.
- Study Id
- D3190C00013
- Disease
- atrial fibrillation
- Drug Name
- AZD1305
- Study Name
- D3190C00013
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Nov 27, 2009
- D3190C00013.pdf (146 KB)
-
expand
To Assess Adherence to the Treatment and Quality of Life in Patients With Hypertension (ADHERENCE)
- Study Id
- NIS-CAR-ATA-2009/1
- Disease
- hypertension
- Drug Name
- Atacand
- Study Name
- NIS-CAR-ATA-2009/1
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Jul 25, 2010
- NIS-CAR-ATA-2009_1.pdf (502 KB)
-
expand
Management of cardiovascular risk factors
- Study Id
- NIS-CCH-DUM-2008/2
- Disease
- cardiovascular diseases
- Drug Name
- non drug study (cardiovascular)
- Study Name
- NIS-CCH-DUM-2008/2
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Dec 2, 2010
- NIS-CCH-DUM-2008/2.pdf (369 KB)
-
expand
Quality of Life and Treatment Satisfaction of People with Type 2 Diabetes: A European Survey
- Study Id
- NIS-CEU-DUM-2008/2
- Disease
- diabetes mellitus
- Drug Name
- non drug study (cardiovascular)
- Study Name
- NIS-CEU-DUM-2008/2
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Nov 12, 2010
- NIS-CEU-DUM-2008/2.pdf (1 GB)
-
expand
A randomized, double-blind, multicentre, placebo-controlled study to evaluate the efficacy, dose-response and safety of tesaglitazar therapy in Japanese subjects with type 2 Diabetes
- Study Id
- D6160L00001
- Disease
- diabetes mellitus
- Drug Name
- Galida
- Study Name
- D6160L00001
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Jan 18, 1971
- D6160L00001.pdf (198 KB)
-
expand
A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study to Evaluate the Effect of Tesaglitazar 1 mg once daily on the Pharmacokinetics of Metformin Following Addition of Tesaglitazar to Metformin IR Treatment twice daily in Patients with Type 2 Diabetes
- Study Id
- D6160C00058
- Disease
- diabetes mellitus
- Drug Name
- Galida
- Study Name
- D6160C00058
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Jan 18, 1971
- D6160C00058.pdf (555 KB)
-
expand
An open-label, non-randomized study to evaluate the effect of tesaglitazar 1 mg once daily doses on ovulation suppression in healthy female volunteers on an combined oral contraceptive containing drospirenone and ethinyl estradiol
- Study Id
- D6160C00057
- Disease
- diabetes mellitus
- Drug Name
- Galida
- Study Name
- D6160C00057
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Jan 18, 1971
- D6160C00057.pdf (530 KB)
-
expand
A Long-Term,Post treatment,Safety Follow-up,Multi-Centre Study in Patients with Type 2 Diabetes Mellitus from the GALLANT, GALLEX or ARMOR Studies
- Study Id
- D6160C00056
- Disease
- diabetes mellitus
- Drug Name
- Galida
- Study Name
- D6160C00056
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Jan 18, 1971
- D6160C00056.pdf (556 KB)
- Expand All
- Collapse All
